Accumulating evidence also shows a beneficial role for DMF in experimental colitis [51,154,155]; this may be due to activation of Nrf2, which results in decreased mitochondrial ROS generation and mitochondrial DNA release, followed by suppression of NLRP3 inflammasome activation [154]. Here, NLRP3 is linked to colitis.